🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Truist lifts Procter & Gamble stock target, retains Buy after Q1 earnings release

EditorNatashya Angelica
Published 10/22/2024, 10:10 PM
© Reuters.
PG
-

On Tuesday, Truist Securities updated its outlook on Procter & Gamble (NYSE:PG) shares, increasing the price target to $180 from the previous $175, while reaffirming a Buy rating on the stock. The adjustment follows the company's first-quarter earnings for fiscal year 2025, which were announced last Friday.

The analyst at Truist Securities provided a follow-up to an earlier note regarding Procter & Gamble's financial performance. Despite a slight reduction in the sales forecast for fiscal year 2025 to $85.785 billion, down from the initial $85.932 billion, the firm expressed a more optimistic view for the following year, raising the fiscal year 2026 sales projection to $88.967 billion from $88.578 billion.

In addition to the sales estimates, Truist Securities has also increased its projections for Procter & Gamble's Core Earnings Per Share (EPS). For fiscal year 2025, the Core EPS estimate has been lifted to $6.95, up from the previous $6.87. For fiscal year 2026, the Core EPS forecast has been elevated to $7.42 from the earlier estimate of $7.26.

The revised 12-month price target to $180 reflects a positive outlook on Procter & Gamble's stock, with the analyst stating, "We are also raising our 12m PT to $180 from $175, prior. We maintain our Buy rating." This statement underscores Truist Securities' continued endorsement of the stock as a good investment opportunity.

In other recent news, Procter & Gamble's recent earnings report showed a 2% rise in organic sales, and North America experienced a 4% increase. The company's core earnings per share (EPS) rose by 5% to $1.93. Despite a strong overall performance, the company faced a 15% decline in sales in China.

Analysts from TD Cowen, Raymond James, and DA Davidson have updated their price targets for Procter & Gamble to $189, $190, and $160 respectively. TD Cowen and Raymond James maintain a positive outlook on the company with a Buy and Outperform rating respectively, while DA Davidson maintains a Neutral rating.

Procter & Gamble plans to return $16 billion to shareholders through dividends and stock repurchases. The company is also targeting $1.5 billion in cost savings for the year. These are all recent developments for Procter & Gamble, which continues to show resilience in its business model.

InvestingPro Insights

Procter & Gamble's strong market position is reflected in its impressive financial metrics and analyst sentiment. According to InvestingPro data, the company boasts a substantial market capitalization of $399.27 billion, underlining its status as a major player in the Household Products industry. This aligns with Truist Securities' optimistic outlook and increased price target.

The company's commitment to shareholder value is evident in its dividend history. InvestingPro Tips highlight that P&G has raised its dividend for 41 consecutive years and has maintained dividend payments for 54 consecutive years. This consistent dividend growth, coupled with a current dividend yield of 2.37%, may appeal to income-focused investors.

Despite the positive outlook, it's worth noting that 12 analysts have revised their earnings downwards for the upcoming period, according to InvestingPro Tips. This could be related to the slight reduction in sales forecast mentioned in the article. However, the company remains profitable, with a P/E ratio of 28.52 and an adjusted P/E ratio of 24.48 for the last twelve months as of Q1 2025.

For investors seeking a more comprehensive analysis, InvestingPro offers additional insights with 11 more tips available for Procter & Gamble, providing a deeper understanding of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.